Summit Therapeutics Inc. (SMMT)
USD 16.98
(-8.56%)
USD 16.98
(-8.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -76.76 Million | -41.58 Million | -72.58 Million | -48.11 Million | -19.98 Million | -35.14 Million |
| Net Income | -614.92 Million | -78.78 Million | -88.6 Million | -52.69 Million | -30.66 Million | 6.59 Million |
| Depreciation & Amortization | 2.05 Million | 2.51 Million | 2.45 Million | 2 Million | 1.78 Million | 1.49 Million |
| Deferred income taxes | -2.79 Million | - | 326 Thousand | 583 Thousand | 396.85 Thousand | 2.97 |
| Stock-based compensation | 11.06 Million | 9.88 Million | 9.46 Million | 1.29 Million | 695.87 Thousand | 6.22 Million |
| Change in working capital | -2.36 Million | 8.61 Million | -67 Thousand | 619 Thousand | 1.22 Million | -51.18 Million |
| Other non-cash items | 530.2 Million | 14.12 Million | 497 Thousand | -385 Thousand | 6.57 Million | 1.72 Million |
| Investing Cash Flow | -587.77 Million | -624 Thousand | -306 Thousand | -421 Thousand | -340.62 Thousand | -410.51 Thousand |
| Investments in PPE | -128 Thousand | -624 Thousand | -306 Thousand | -421 Thousand | -340.62 Thousand | -163.94 Thousand |
| Acquisitions | 226 Thousand | - | - | - | -127.34 Thousand | -251.81 Thousand |
| Investment purchases | -321.02 Million | - | - | - | - | - |
| Sales/Maturities of investments | 208.16 Million | - | - | - | - | - |
| Other Investing Activities | -475.01 Million | -600.00 | - | - | 15.34 Thousand | 5246.25 |
| Financing Cash Flow | 86.51 Million | 620.24 Million | 77.91 Million | 50.55 Million | 48.09 Million | 43.85 Million |
| Debt repayment | -24.68 Million | -25 Million | -110 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 5 Million | 100 Million | 75 Million | 50 Million | 48.55 Million | 45.44 Million |
| Other Financing Activities | 106.19 Million | 545.24 Million | 112.91 Million | 551 Thousand | 40.76 Million | -1.58 Million |
| Accounts receivables | 359 Thousand | 975 Thousand | -1.13 Million | 212 Thousand | 5.94 Million | - |
| Accounts payables | 2.26 Million | -4.13 Million | -1.71 Million | 1.64 Million | -1.28 Million | - |
| Inventory | - | - | 3.59 Million | -6.6 Million | -2.00 | - |
| Other working capital | -4.99 Million | 11.77 Million | -813 Thousand | 5.37 Million | -3.43 Million | - |
| Cash at beginning of period | 648.6 Million | 71.79 Million | 66.41 Million | 63.84 Million | 28.58 Million | 26.36 Million |
| Cash at end of period | 71.42 Million | 648.6 Million | 71.79 Million | 66.41 Million | 64.14 Million | 35.22 Million |
| Capital Expenditure | -128 Thousand | -624 Thousand | -306 Thousand | -421 Thousand | -340.62 Thousand | -163.94 Thousand |
| Effect of forex changes on cash | 839 Thousand | -1.22 Million | 351 Thousand | 556 Thousand | 156.46 Thousand | 560.03 Thousand |
| Net cash flow / Change in cash | -577.18 Million | 576.81 Million | 5.37 Million | 2.57 Million | 35.55 Million | 8.86 Million |
| Free Cash Flow | -76.88 Million | -42.2 Million | -72.89 Million | -48.53 Million | -20.32 Million | -35.3 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -56.25 Million | -60.38 Million | -43.47 Million | -36.56 Million | -614.92 Million | -21.26 Million |
| Depreciation & Amortization | 20 Thousand | 20 Thousand | 27 Thousand | 605 Thousand | 2.05 Million | 599 Thousand |
| Deferred income taxes | - | - | - | -648 Thousand | -2.79 Million | 1.69 Million |
| Stock-based compensation | 19.37 Million | 11.08 Million | 7.53 Million | 6.86 Million | 11.06 Million | 577.86 Thousand |
| Change in working capital | 8.96 Million | 2.98 Million | 4.19 Million | 8.31 Million | -2.36 Million | 3.44 Million |
| Other non-cash items | -2.39 Million | 27.75 Million | 10.61 Million | 82 Thousand | 527.16 Million | -63 Thousand |
| Investing Cash Flow | -108.61 Million | -199.64 Million | 19.87 Million | 60.56 Million | -587.77 Million | -3.48 Million |
| Investments in PPE | -58 Thousand | -62.83 Thousand | -4000.00 | -2000.00 | -128 Thousand | -53 Thousand |
| Acquisitions | - | - | - | -4860.75 | 226 Thousand | 993.19 |
| Investment purchases | -167.54 Million | -269.13 Million | -92.98 Million | 1000.00 | -321.02 Million | -112.85 Million |
| Sales/Maturities of investments | 73.99 Million | 69.55 Million | 112.85 Million | 60.56 Million | 208.16 Million | 109.42 Million |
| Other Investing Activities | -15 Million | - | 15.69 Million | 4860.75 | -475.01 Million | -993.19 |
| Financing Cash Flow | 204.14 Million | 199.72 Million | 485 Thousand | 6.25 Million | 86.51 Million | 229 Thousand |
| Debt repayment | -75.5 Million | - | - | -2.07 Million | -24.68 Million | -1.65 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 277.99 Million | 199.72 Million | 485 Thousand | 3.98 Million | 5 Million | 693.67 Thousand |
| Other Financing Activities | 1.64 Million | 200.21 Million | 396.23 Thousand | 4.34 Million | 106.19 Million | 1.19 Million |
| Accounts receivables | 260 Thousand | -155.15 Thousand | 632 Thousand | -278.84 Thousand | 359 Thousand | 3000.00 |
| Accounts payables | -188 Thousand | -3.03 Million | 3.7 Million | -672 Thousand | 2.26 Million | 2.33 Million |
| Inventory | - | - | - | 278.84 Thousand | - | - |
| Other working capital | 8.89 Million | 6.17 Million | -92 Thousand | 8.98 Million | -4.99 Million | 1.1 Million |
| Cash at beginning of period | 28.75 Million | 61.61 Million | 71.42 Million | 23.79 Million | 648.6 Million | 42.11 Million |
| Cash at end of period | 94.09 Million | 28.75 Million | 61.61 Million | 71.42 Million | 71.42 Million | 23.79 Million |
| Capital Expenditure | -58 Thousand | -62.83 Thousand | -4000.00 | -2000.00 | -128 Thousand | -53 Thousand |
| Effect of forex changes on cash | 114 Thousand | 12 Thousand | -36 Thousand | 272 Thousand | 839 Thousand | -170 Thousand |
| Net cash flow / Change in cash | 65.34 Million | -32.85 Million | -9.81 Million | 47.63 Million | -577.18 Million | -18.32 Million |
| Free Cash Flow | -30.35 Million | -32.91 Million | -30.13 Million | -19.46 Million | -76.88 Million | -14.95 Million |
MAAFF
0071
0207
AIRYY
5255
JBL